CIVCO Advances Real-Time Planning for Brachytherapy with New EX3™ Stepper

CORALVILLE, Iowa, Nov. 20, 2013 /PRNewswire/ -- CIVCO Medical Solutions advances the standard in real-time planning with FDA 510(k) clearance of the EX3 Stepper for Low Dose Rate (LDR) and High Dose Rate (HDR) ultrasound-guided brachytherapy for prostate cancer detection and treatment.  

(Logo: http://photos.prnewswire.com/prnh/20110419/AQ85801LOGO)

LDR prostate brachytherapy involves internal radiotherapy where tiny radioactive 'seeds' are delivered through a needle and are permanently placed into or near the tumor for treatment.  HDR prostate brachytherapy is a similar internal treatment that involves the temporary placement of a tiny radioactive source directly into the tumor or near the targeted treatment area.

The EX3 Stepper's modular design reports angular and linear position directly to the manufacturer's treatment planning software intraoperatively.  Through direct communication, the stepper offers rapid connection for data analysis and reduces clutter in the surgical suite. The unique design of the EX3 also features a removable electronic unit which mitigates the risk of damaging transmission components and reduces cleaning time after the procedure.

CIVCO's EX3 Stepper, like its predecessor the EXII^™, offers compatibility for BK Medical, GE Healthcare, Hitachi Aloka and Siemens transrectal ultrasound probes and it is currently validated for use with Varian Vitesse^™ and VariSeed^™ treatment planning software.

In addition to receiving FDA 510(k) clearance, CIVCO has also CE Marked the EX3 for sale in the European Union and other countries where the CE Mark is recognized.

Contact CIVCO today for more information at 319.248.6757 or [email protected].

About CIVCO

CIVCO Medical Solutions has over 30 years of experience and offers cutting-edge medical technology to a diverse group of medical professionals. The Multi-Modality Imaging (MMI) unit designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures with a strong focus on ultrasound. MMI's products range from infection control products including a wide range of ultrasound and CT covers to device guidance, positioning and electromagnetic needle tracking. CIVCO's Radiation Oncology (RO) division designs, manufactures and markets comprehensive motion management solutions to improve patient outcomes and increase clinical productivity for head and neck, breast, lung, abdomen, prostate and other treatment sites. RO's products include couchtops and overlays for linear accelerators and imaging systems, advanced patient immobilization solutions, robotic patient positioning, advanced fiducial markers, and immobilization/positioning equipment and consumables. CIVCO offers patients and clinicians the newest and best technology available to improve patient care. Corporate information is available at WWW.CIVCO.COM.

For more information, please contact:               

                Paul Bagli
                Director of Sales & Project Manager, Surgical
                CIVCO Medical Solutions
                Tel: 813.966.9649
                [email protected]

COPYRIGHT © 2013. CIVCO IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS. ALL OTHER TRADEMARKS ARE PROPERTY OF THEIR RESPECTIVE OWNER. ALL PRODUCTS MAY NOT BE LICENSED IN ACCORDANCE WITH CANADIAN LAW. 2013C-2692

SOURCE CIVCO Medical Solutions

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED